Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods

1. A. E. Raizner, Coenzyme Q₁₀, Methodist Debakey Cardiovasc. J. 15(3) (2019) 185–191; https://doi.org/10.14797/mdcj-15-3-185682264431687097 Search in Google Scholar

2. T. Hidaka, K. Fujii, I. Funahashi, N. Fukutomi and K. Hosoe, Safety assessment of coenzyme Q10 (CoQ10), Biofactors 32(1–4) (2008) 199–208; https://doi.org/10.1002/biof.552032012419096117 Search in Google Scholar

3. B. A. Taylor, Does coenzyme Q10 supplementation mitigate statin-associated muscle symptoms? Pharmacological and methodological considerations, Am. J. Cardiovasc. Drugs 18(2) (2018) 75–82; https://doi.org/10.1007/s40256-017-0251-229027135 Search in Google Scholar

4. K. H. Bhandari, M. Newa, J. A. Kim, B. K. Yoo, J. S. Woo, W. S. Lyoo, H. T. Lim, H. G. Choi and C. S. Yong, Preparation, characterization and evaluation of coenzyme Q10 binary solid dispersions for enhanced solubility and dissolution, Biol. Pharm. Bull. 30(6) (2007) 1171–1176; https://doi.org/10.1248/bpb.30.117117541177 Search in Google Scholar

5. K. Westesen, Novel lipid-based colloidal dispersions as potential drug administration systems – expectations and reality, Colloid Polym. Sci. 278(7) (2000) 608–618; https://doi.org/10.1007/s003969900257 Search in Google Scholar

6. S. Xia, S. Xu and X. Zhang, Optimization in the preparation of coenzyme Q10 nanoliposomes, J. Agric. Food Chem. 54(17) (2006) 6358–6366; https://doi.org/10.1021/jf060405o16910731 Search in Google Scholar

7. J. Garrido-Maraver, M. D. Cordero, M. Oropesa-Ávila, A. F. Vega, M. de la Mata, A. Delgado Pavón, M. de Miguel, C. Pérez Calero, M. Villanueva Paz, D. Cotán and J. A. Sánchez-Alcázar, Coenzyme q10 therapy, Mol. Syndromol. 5(3–4) (2014) 187–197; https://doi.org/10.1159/000360101411252525126052 Search in Google Scholar

8. D. L. Hansen, D. Tulinius and E. H. Hansen, Adolescents’ struggles with swallowing tablets: barriers, strategies and learning, Pharm. World Sci. 30(1) (2008) 65–69; https://doi.org/10.1007/s11096-007-9142-y17594531 Search in Google Scholar

9. R. Matsui, O. Ueda, S. Uchida and N. Namiki, Transdermal absorption of natural progesterone from alcoholic gel formulations with hydrophilic surfactant, Drug Dev. Ind. Pharm. 41(6) (2015) 1026–1029; https://doi.org/10.3109/03639045.2014.92591524980912 Search in Google Scholar

10. C. Cecchi and P. L. Canonico, Pharmaceutical formulations and adherence to pharmacological treatment in psychiatry: the example of oral disintegrating tablet of olanzapine, Riv. Psichiatr. 47(1) (2012) 30–39; https://doi.org/10.1708/1034.1128922358215 Search in Google Scholar

11. H. Ascher-Svanum, N. M. Furiak, A. H. Lawson, T. M. Klein, L. J. Smolen, R. R. Conley and S. D. Culler, Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States, J. Med. Econ. 15(3) (2012) 531–547; https://doi.org/10.3111/13696998.2012.66292322304338 Search in Google Scholar

12. N. Namiki, Clinical functionality required for orally disintegrating tablets selected as the next generation type, Yakugaku Zasshi 135(2) (2015) 237–243; https://doi.org/10.1248/yakushi.14-00228-325747219 Search in Google Scholar

13. S. Paul, L. J. Taylor, B. Murphy, J Krzyzaniak, N. Dawson, M. P. Mullarney, P. Meenan and C. C. Sun, Mechanism and kinetics of punch sticking of pharmaceuticals, J. Pharm. Sci. 106(1) (2016) 151–158; https://doi.org/10.1016/j.xphs.2016.07.01527649886 Search in Google Scholar

14. F. Jin and A. Tatavarti, Tabletability assessment of conventional formulations containing vitamin E tocopheryl polyethylene glycol succinate, Int. J. Pharm. 389(1–2) (2010) 58–65; https://doi.org/10.1016/j.ijpharm.2010.01.01720083178 Search in Google Scholar

15. Y. Ikematsu, S. Uchida and N. Namiki, Preparation and evaluation of orally disintegrating tablets containing vitamin E as a model fat-soluble drug, Chem. Pharm. Bull. 63(3) (2015) 156–163; https://doi.org/10.1248/cpb.c14-0059825757486 Search in Google Scholar

16. N. M. Zaki, Strategies for oral delivery and mitochondrial targeting of CoQ10, Drug Deliv. 23(6) (2016) 1868–1881; https://doi.org/10.3109/10717544.2014.99374725544601 Search in Google Scholar

17. A. Martucci, D. Reurean-Pintilei and A. Manole, Bioavailability and sustained plasma concentrations of CoQ10 in healthy volunteers by a novel oral timed-release preparation, Nutrients 11(3) (2019) Article ID 527 (13 pages); https://doi.org/10.3390/nu11030527647138730823449 Search in Google Scholar

18. M. Davis and G. Walker, Recent strategies in spray drying for the enhanced bioavailability of poorly water-soluble drugs, J. Control. Release 269 (2018) 110–127; https://doi.org/10.1016/j.jconrel.2017.11.00529117503 Search in Google Scholar

19. T. Niwa and K. Danjo, Design of self-dispersible dry nanosuspension through wet milling and spray freeze-drying for poorly water-soluble drugs, Eur. J. Pharm. Sci. 50(3–4) (2013) 272–281; https://doi.org/10.1016/j.ejps.2013.07.01123907001 Search in Google Scholar

20. M. Kidokoro, Y. Haramiishi, S. Sagasaki, T. Shimizu and Y. Yamamoto, Application of fluidized hot-melt granulation (FHMG) for the preparation of granules for tableting; properties of granules and tablets prepared by FHMG, Drug Dev. Ind. Pharm. 28(1) (2002) 67–76; https://doi.org/10.1081/ddc-12000148711858526 Search in Google Scholar

21. Y. Takashima, H. Yuasa, Y. Kanaya, I. Nomura and K. Shinozawa, Reduction of tablet coloration at tableting for oily medicine (tocopheryl nicotinate), Int. J. Pharm. 187(1) (1999) 125–135; https://doi.org/10.1016/s0378-5173(99)00179-910502619 Search in Google Scholar

22. Y. Kato and M. Takeno, Improvement of content uniformity of d-alpha-tocopheryl acetate as an oily drug in granules by emulsification, Drug Dev. Ind. Pharm. 32(5) (2006) 617–621; https://doi.org/10.1080/0363904050052903616723312 Search in Google Scholar

23. T. Koseki, H. Onishi, Y. Takahashi, M. Uchida and Y. Machida, Development of novel fast-disintegrating tablets by direct compression using sucrose stearic acid ester as a disintegration-accelerating agent, Chem. Pharm. Bull. 56(10) (2008) 1384–1388; https://doi.org/10.1248/cpb.56.138418827375 Search in Google Scholar

24. Food and Drug Administration, Center for Drug Evaluation and Research (CDER), “Guidance for Industry: Orally Disintegrating Tablets,” U.S. Department of Health and Human Services, U.S.A., December 2008; https://www.fda.gov/media/70877/download last access date March 31, 2022. Search in Google Scholar

25. T. Sakamoto, S. Kachi, S. Nakamura and H. Yuasa, Potential use of magnesium oxide as an excipient to maintain the hardness of orally disintegrating tablets during unpackaged storage, Chem. Pharm. Bull. 67(3) (2019) 284–288; https://doi.org/10.1248/cpb.c18-0058830828006 Search in Google Scholar

26. K. Hori, N. Yoshida, T. Okumura, Y. Okamura and J. Kawakami, Method for the evaluation of the stability and usability after opening packages of orally disintegrating tablets: case of amlodipine besilate products, Yakugaku Zasshi 130(8), (2010) 1029–1040; https://doi.org/10.1248/yakushi.130.102920686207 Search in Google Scholar

27. S. M. Wong, I. W. Kellaway and S. Murdan, Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles, Int. J. Pharm. 317(1) (2006) 61–68; https://doi.org/10.1016/j.ijpharm.2006.03.00116647232 Search in Google Scholar

28. K. Terao, D. Nakata, H. Fukumi, G. Schmid, H. Arima, F. Hirayama and K. Uekama, Enhancement of oral bioavailability of coenzyme Q10 by complexation with γ-cyclodextrin in healthy adults, Nutrition Res. 26(10) (2006) 503–508; https://doi.org/10.1016/j.nutres.2006.08.004 Search in Google Scholar

29. B. Abdulwahab, S. Ranjita, D. Michael and H. M. Rainer, Coenzyme Q10 oral bioavailability: effect of formulation type, J. Pharm. Investig. 43(6) (2013) 431–451; https://doi.org/10.1007/s40005-013-0101-4 Search in Google Scholar

30. J. Hatanaka, Y. Kimura, Z. Lai-Fu, S. Onoue, S. Yamada, Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations, Int. J. Pharm. 363(1–2) (2008) 112–117; https://doi.org/10.1016/j.ijpharm.2008.07.01918706989 Search in Google Scholar

31. C. J. Pastor-Maldonado, J. M. Suárez-Rivero, S. Povea-Cabello, M. Álvarez-Córdoba, I. Villalón-García, M. Munuera-Cabeza, A. Suárez-Carrillo, M. Talaverón-Rey and J. A. Sánchez-Alcázar, Coenzyme Q(10): Novel formulations and medical trends, Int. J. Mol. Sci. 21(22) (2020) Article ID 8432 (23 pages); https://doi.org/10.3390/ijms21228432769779933182646 Search in Google Scholar